Clinical Trial

A Study to Evaluate the Safety and Performance of Dr Korman Laboratories' Hyaluronic Acid Filler 20 mg/mL With Lidocaine for Lip Augmentation

Recruiting
View on ClinicalTrials.gov →
Summary
This study will assess the safety and effectiveness of a dermal filler called DKL crosslinked hyaluronic acid 20 mg/mL with lidocaine 0.3% when injected into the lips of healthy men and women who want to have fuller lips. The change in the appearance of the lips will be checked.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-24.
Status change: Not Yet Recruiting → Recruiting 2026-05-13
Trial Details
NCT Number NCT07204691
Lead Sponsor Dr. Korman Laboratories Ltd.
Collaborators: CTC Clinical Trial Consultants AB
Conditions Lip Augmentation
Enrollment 75 participants
Start Date 2025-09-24
Primary Completion 2026-02-12 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-05-15